Trials / Sponsors / MeiraGTx UK II Ltd

MeiraGTx UK II Ltd

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Completed	Gene Therapy for Achromatopsia (CNGA3) Achromatopsia	Phase 1 / Phase 2	2019-08-12
Completed	A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 i Radiation-Induced Parotid Gland Hypofunction, Xerostomia Due to Radiotherapy, Head and Neck Cancer	Phase 1	2019-06-30
Completed	Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigme Retinitis Pigmentosa	—	2017-12-19
Completed	Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR) X-Linked Retinitis Pigmentosa	Phase 1 / Phase 2	2017-07-31
Terminated	Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3 Achromatopsia	—	2017-06-29
Completed	Gene Therapy for Achromatopsia (CNGB3) Achromatopsia	Phase 1 / Phase 2	2017-01-16
Completed	Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated Leber Congenital Amaurosis (LCA), Eye Diseases, Eye Diseases, Hereditary	—	2016-11-01
Completed	Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA) Leber Congenital Amaurosis	Phase 1 / Phase 2	2016-04-01
Completed	Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65 Leber Congenital Amaurosis	—	2016-04-01
Completed	Natural History Study for Achromatopsia Achromatopsia	—	2011-09-13